Posts Tagged ‘Funding’
iOnctura announces €80 Million Series B
iOnctura, a clinical-stage biopharmaceutical company combating neglected and hard-to-treat cancers, announced that it has closed an €80 Million Series B financing. The funding round was led by new investor Syncona Limited with participation by the EIC Fund, the venture arm of the European Innovation Council (EIC), as well as existing investors M Ventures, Inkef Capital,…
Read MoreHekeTiss gets CHF 100’000 seed loan from FONGIT Innovation Fund (FIF)
The FONGIT Innovation Fund (FIF) in Geneva has awarded new funding to three cutting-edge tech projects including HekeTiss. UNIGE and HUG spinoff HekeTiss, an award-winning startup, has secured a Seed Loan of CHF 100’000, building on their previous FIF Grant of CHF 50,000 awarded in 2022. HekeTiss has developed trophiPatch, an innovative treatment…
Read MoreLimula raises CHF 6.2 Million
Limula raises CHF 6.2 Million in oversubscribed Seed round to develop automated Cell and Gene Therapy manufacturing platform. The oversubscribed seed round was led by LifeX Ventures, with participation from the founders, Verve Ventures, Zühlke Ventures, Oxford Seed Fund, Lichtsteiner Foundation, W.A. de Vigier Foundation, and a line-up of private individuals who have…
Read MoreOrio Therapeutics receives CHF 150’000 from Venture Kick
Orio Therapeutics obtains the CHF 150,000 Kick to redefine regenerative medicine through protein engineering. Orio Therapeutics modifies therapeutic proteins using a patented technology. This modification improves drug delivery by controlling the localisation of the protein after injection. Its approach ensures enhanced efficacy and reduced dosage, addressing the limitations of uncontrolled drug delivery in…
Read MoreDAAV secures CHF 1 Million
DAAV, a pioneering startup revolutionising mobility services for people with reduced mobility, announced the successful closure of its first funding round. The investment was led by Spicehaus Partners. DAAV is dedicated to providing an inclusive travel experience for individuals with reduced mobility, particularly in airport settings. With its AI-enabled mobility device, DAAV-air, the…
Read MoreTestmate Health raises $6 Million
Testmate Health announced the successful closing of their $6 Million funding round led by RH Capital to continue their development of the first at-home rapid test for sexually transmitted infections (STIs). The round was led by women’s health fund RH Capital, with participation from Tia and Oova backer The Helm, Dame and Playground…
Read MoreiOnctura partners with the Dutch Cancer Society
iOnctura announced that they have been awarded funding from the KWF Kankerbestrijding / Dutch Cancer Society to further the development of IOA-289 for fibrotic tumours. This project focuses on a new drug for cancers with high levels of connective tissue formation, such as pancreatic cancer. The aim is to inhibit ‘bad’ connective tissue…
Read MoreSpineart and SpinEM Robotics forge strategic partnership with €10 Million Investment
Spineart’s journey towards innovation and leadership in the field of spinal surgery continues. The Geneva-based company announced a strategic partnership with SpinEM Robotics SAS, a leading deep tech startup specialising in cutting-edge navigation solutions for robotic spinal surgery. This investment marks the beginning of an exciting development collaboration between SpinEM Robotics and Spineart.…
Read MoreAzur Cell Therapies and Antion Biosciences get funding from FONGIT Innovation Fund (FIF)
The FONGIT Innovation Fund (FIF) continues to bolster the growth of new technologies in Geneva, with its latest grants awarded to Azure Cell Therapies and Antion Biosciences for their innovative projects that are poised to impact not only Geneva’s economic growth but also global advancements. The FONGIT Innovation Fund (FIF) fosters innovation and…
Read MoreVolumina Medical secures USD 21 Million Funding
Volumina Medical, a clinical stage MedTech company developing novel biomaterials for dermatology and plastic surgery, announces the successful closing of their Series A round by existing and new investors. It will enable Volumina Medical to confidently advance its clinical program with its lead product AdipearlTM, and ultimately achieve market approval in key international markets. …
Read More